🌈𝐃𝐫𝐮𝐠 𝐫𝐞𝐜𝐚𝐥𝐥: 𝐃𝐢𝐠𝐨𝐱𝐢𝐧 𝐓𝐚𝐛𝐥𝐞𝐭𝐬 𝐫𝐞𝐜𝐚𝐥𝐥𝐞𝐝 𝐝𝐮𝐞 𝐭𝐨 𝐥𝐚𝐛𝐞𝐥 𝐦𝐢𝐱-𝐮𝐩
🍁Drug recall: In New Castle, Delaware, Marlex Pharmaceuticals, Inc. is voluntarily recalling one lot of Digoxin Tablets USP, 0.125 mg, and one lot of Digoxin Tablets USP, 0.25 mg, to the consumer level due to a label mix-Up.
🍁Bottles of Digoxin Tablets, USP 0.125mg, are incorrectly labeled and contain Digoxin Tablets, USP, 0.25mg.
Bottles of Digoxin Tablets USP, 0.25 mg, are incorrectly labeled and contain Digoxin Tablets USP, 0.125mg.
🍁The mix-up in labels can cause either overdosing or underdosing in patients who unknowingly take the wrong dose.
🍁Patients who intend to take Digoxin Tablets USP, 0.25mg, but unknowingly take Digoxin 0.125mg would receive a sub potent dose, which may lead to loss of control of heart rate and a potential heart failure exacerbation.
Source: Thehealthmaster
#pharma #pharmaceutical
Terrific to know a company who stays dedicated to supporting T1D's.